Hi everyone,
I got a phone call today from the Dr who I saw at UCSF in July for a second opinion. He reviewed the results from the UCSF 500 genetic testing with me. He told me that my KRAS gene was not mutated which confirmed why I was responding to Erbitux. He said no other mutatations were found so it didn't point to any different direction treatment wise. That's what I got out of his comment anyway. I was actually getting my chemo when he called so I listened more than I talked. He recommended that I stay on current regimen which I was tolerating and showing positive response. We discussed possible clinical trials down the road if I hit a wall with current treatment, but did not recommend that route based on where I was now.
Are there any other questions that I should have asked? I can e-mail them to him through the UCSF portal. Are there other markers or results that I should be aware of?
Chemo break week was great but back on the wagon now! I actually look forward to chemo which sounds crazy but it's my only weapon so it makes sense in this world.
Thanks for any suggestions and feedback!